Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Frisell

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
The Lancet. Oncology|August 9, 2024
Completion axillary lymph node dissection for the identification of pN2-3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trialJana de Boniface, Matilda Appelgren, Robert Szulkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2016
Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 SubtypesJingmei Li, Emma Ivansson, Daniel Klevebring, et al.
JAMA Surgery|September 25, 2024
Prediction of High Nodal Burden in Patients With Sentinel Node-Positive Luminal ERBB2-Negative Breast CancerIda Skarping, Pär-Ola Bendahl, Robert Szulkin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2024
Quality assessment of radiotherapy in the prospective randomized SENOMAC trialSara Alkner, Elinore Wieslander, Dan Lundstedt, et al.
Acta Oncologica (Stockholm, Sweden)|February 16, 2016
Time trends in axilla management among early breast cancer patients: Persisting major variation in clinical practice across European centersAdam Gondos, Lina Jansen, Jörg Heil, et al.
The New England Journal of Medicine|April 10, 2024
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node MetastasesJana de Boniface, Tove Filtenborg Tvedskov, Lisa Rydén, et al.
Breast Cancer Research and Treatment|March 6, 2023
Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologistsCarl Sars, Helena Sackey, Jan Frisell, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
The Lancet. Oncology|August 9, 2024
Completion axillary lymph node dissection for the identification of pN2-3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trialJana de Boniface, Matilda Appelgren, Robert Szulkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2016
Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 SubtypesJingmei Li, Emma Ivansson, Daniel Klevebring, et al.
JAMA Surgery|September 25, 2024
Prediction of High Nodal Burden in Patients With Sentinel Node-Positive Luminal ERBB2-Negative Breast CancerIda Skarping, Pär-Ola Bendahl, Robert Szulkin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2024
Quality assessment of radiotherapy in the prospective randomized SENOMAC trialSara Alkner, Elinore Wieslander, Dan Lundstedt, et al.
Acta Oncologica (Stockholm, Sweden)|February 16, 2016
Time trends in axilla management among early breast cancer patients: Persisting major variation in clinical practice across European centersAdam Gondos, Lina Jansen, Jörg Heil, et al.
The New England Journal of Medicine|April 10, 2024
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node MetastasesJana de Boniface, Tove Filtenborg Tvedskov, Lisa Rydén, et al.
Breast Cancer Research and Treatment|March 6, 2023
Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologistsCarl Sars, Helena Sackey, Jan Frisell, et al.
Pageof 5